News
Ali KhademhosseiniProf. Ali Khademhosseini is a professor of biomedical engineering and medicine at Harvard Medical School and a faculty member at the Harvard–Massachusetts Institute of Technology (MIT) Division of Health Science and Technology and at Brigham and Women’s Hospital, as well as an…
On April 21 and 22, 2016, Monash Institute of Pharmaceutical Sciences (MIPS) in Melbourne hosted the 2016 Joint Annual Australian–New Zealand CRS Student Workshop
Zach Houston finishes his presentation in front of the magnificent Sissons Mural at Monash Parkville campus.under the theme “Crossing…
Introduction
Therapeutically relevant proteins such as antibodies, growth factors, and enzymes play an increasing role in the treatment of malignant and autoimmune diseases. However, they often suffer from insufficient stability and poor bioavailability. A suitable method to increase protein…
Vinod LabhasetwarDDTR First Impact Factor 1.887
We are pleased to announce the first DDTR impact factor (IF) of 1.887. This two-year IF is based on total number of citations in 2015 for the articles published in 2014 and 2013. The five-year IF is 1.917, which is the average number of times…
MyCRS president Mohd Cairul Iqbal Mohd Amin presents the best poster award to Benchawan Chamsai.The CRS Malaysia Local Chapter (MyCRS) took part in Pharma+BioAsia 2016 as a Knowledge Partner. The meeting was held September 28–29 at the Kuala Lumpur Convention Centre, Kuala Lumpur, Malaysia. MyCRS’s…
The 44th CRS annual meeting was held in Boston, Massachusetts, the “City of Champions.” Like the five-time Super Bowl champions, the New England Patriots, Boston has always been a champion of pharmaceutical innovation. In fact, Bloomberg Business ranked Massachusetts the #1 state for innovation…
